Decreased FOXO1 expression in insulin receptor knockout mice has been shown to lead to lower lipid deposition in the liver (Matsumoto et al., 2007), which suggests that FOXO1 may be regulate NAFLD progression. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.